A 22 year follow-up study on lymphatic filariasis in Tanzania: analysis of immunological responsiveness in relation to long-term infection pattern.

Authors:
Address: DBL-Centre for Health Research and Development, Faculty of Life Sciences, University of Copenhagen, Copenhagen, Denmark. pabc@steno.dk
Journal:

Publication:

abstract

Seventy-one individuals who had been examined for Wuchereria bancrofti microfilaraemia in 1975, some of whom had been offered mass treatment with diethylcarbamazine (DEC) in subsequent years, were re-identified in 1996 and examined for microfilaraemia, circulating filarial antigenemia and cellular and humoral immunoresponsiveness to crude antigen homogenates prepared from Brugia pahangi parasite material. 85.9% of the study individuals had the same infection status in 1975 and 1996, suggesting strong predisposition to infection over extended periods of time. IL-4, IL-5 and IFNγ responses were associated with being infection negative in 1996 whereas IL-10 responses were associated with being infection positive. Similarly, specific IgG3 and IgE were strongly associated with being infection negative in 1996 whereas specific IgG4, and thus high IgG4/IgE ratios, were strongly associated with being infection positive. Intermediary levels of mainly IL-5, IFNγ and PBMC stimulation indices were observed for study individuals who changed from being infection positive in 1975 to infection negative in 1996, or vice versa, suggesting a transition in cellular immunoresponsiveness associated with changing infection status. The findings suggest that some people are more disposed to infection with bancroftian filariasis than others and that this is largely unaffected by treatment with DEC. The findings also suggest that specific cellular and antibody responses are more related to current than past infection status, and that IL-4, IL-5, IFNγ, specific IgG3 and IgE are associated with parasite clearance, whereas IL-10 and specific IgG4 are associated with parasite protection.

Related Articles
Lymphatic filariasis-specific immune responses in relation to lymphoedema grade and infection status. II. Humoral responses.
Trans R Soc Trop Med Hyg. 2002
Lymphatic filariasis-specific immune responses in relation to lymphoedema grade and infection status. II. Humoral responses.
Nielsen NO, Bloch P, Simonsen PE. Trans R Soc Trop Med Hyg. 2002 Jul-Aug; 96(4):453-8.
Bancroftian filariasis in Tanzania: specific antibody responses in relation to long-term observations on microfilaremia.
Am J Trop Med Hyg. 1998
Bancroftian filariasis in Tanzania: specific antibody responses in relation to long-term observations on microfilaremia.
Simonsen PE, Meyrowitsch DW. Am J Trop Med Hyg. 1998 Nov; 59(5):667-72.
Bancroftian filariasis in Kwale District of Kenya. II. Humoral immune responses to filarial antigens in selected individuals from an endemic community.
Ann Trop Med Parasitol. 1994
Bancroftian filariasis in Kwale District of Kenya. II. Humoral immune responses to filarial antigens in selected individuals from an endemic community.
Estambale BB, Simonsen PE, Vennervald BJ, Knight R, Bwayo JJ. Ann Trop Med Parasitol. 1994 Apr; 88(2):153-61.
Lymphatic filariasis-specific immune responses in relation to lymphoedema grade and infection status. I. Cellular responses.
Trans R Soc Trop Med Hyg. 2002
Lymphatic filariasis-specific immune responses in relation to lymphoedema grade and infection status. I. Cellular responses.
Nielsen NO, Bloch P, Simonsen PE. Trans R Soc Trop Med Hyg. 2002 Jul-Aug; 96(4):446-52.
Review Experimental infection of humans with filariae.
Rev Infect Dis. 1991
Review Experimental infection of humans with filariae.
Nutman TB. Rev Infect Dis. 1991 Sep-Oct; 13(5):1018-22.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.